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(HYPITAT-II): a multicentre, open-label randomised
controlled trial
Kim Broekhuijsen1*, Josje Langenveld2, Gert-Jan van Baaren3, Mariëlle G van Pampus4, Anton H van Kaam3,
Henk Groen5, Martina Porath6, Maureen TM Franssen1, Ben W Mol3 and HYPITAT-II study groupThe earliest draft versions of the protocol for our study
described the composite adverse maternal outcome as
one or more of progression to severe disease, pulmonary
edema, thrombo-embolic disease, HELLP syndrome,
eclampsia, placental abruption or maternal death. How-
ever, there is ongoing debate as to whether progression
to severe disease should be considered an adverse mater-
nal outcome [1,2]. Therefore, after obtaining funding
which enabled us to increase our sample size to the
current sample size of 680, we decided to study a com-
posite adverse maternal outcome excluding progression
to severe disease. These changes were incorporated in
the protocol as submitted to and approved by the instu-
tional review board;* the current protocol is available
from our website (http://www.studies-obsgyn.nl/hypitat2/
page.asp?page_id=642). Unfortunately, the change to the
maternal outcome definition was not incorporated into
the published protocol, which incorrectly includes pro-
gression to severe disease in the composite adverse mater-
nal outcome [3].
We also discovered minor differences between the
published protocol and the IRB approved protocol. The
definition for neonatal morbidity should have contained
meconium aspiration syndrome, pneumothorax and/or
pneumomediastinum, periventricular leucomalacia, con-
vulsions and other neurological abnormalities. Finally,
low 5-minute Apgar score should have been defined as
below 7 (as opposed to below 3), and low umbilical ar-
tery pH as below 7.05 (as opposed to below 7.0).* Correspondence: k.broekhuijsen@gmail.com
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